A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients.

O'Shaughnessy, J A

A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Oct 1994 - 709-16 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

0923-7534

10.1093/oxfordjournals.annonc.a058975 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Dyspnea--etiology
Escherichia coli
Fluorouracil--administration & dosage
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
Humans
Hypotension--etiology
Leucovorin--administration & dosage
Middle Aged
Neoplasm Staging
Neutropenia--chemically induced
Recombinant Proteins--adverse effects
Regression Analysis
Remission Induction
Survival Rate